GGrantIndex
Sort

172,184 grants matching inflammation

Impact of smoking and its cessation on systemic and airway immune activation

$792,371
Nina H. Lin · Boston Medical Center · R01 · FY2017 · DA

Host epigenetic and mitochondrial function in HIV-infected children

$792,341
Louise Kuhn · Columbia University Health Sciences · R01 · FY2012 · HD

Air Particulate, Metals, and Cognitive Performance in an Aging Cohort- Roles of Circulating Extracellular Vesicles and Non-coding RNAs

$792,334
Joel D Schwartz · Harvard School Of Public Health · R01 · FY2017 · ES

A Longitudinal Study of Periodontal Infections and Alzheimer's Disease: The WHICAP Ancillary Study of Oral Health

$792,319
James McCallum Noble · Columbia University Health Sciences · R01 · FY2023 · AG

VISTA is a negative checkpoint regulator of innate immunity

$792,298
Sladjana Skopelja-Gardner · Dartmouth College · R01 · FY2024 · AI

Ga68-DOTATATE PET imaging of plaque inflammation

$792,197
Zahi A. Fayad · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · HL

ASTHMA CLINICAL RESEARCH NETWORK

$792,154
Brigham And Women'S Hospital · U10 · FY2001 · HL

Collaborative multi-site project to speed the identification and management of rare genetic immune diseases

$792,119
Manish J Butte · University Of California Los Angeles · R01 · FY2022 · AI

Air Pollution and Preclinical Atherosclerosis in Elementary-School Children

$792,079
Edward Avol · University Of Southern California · R01 · FY2007 · ES

Microbial and Host Factors in the Progression to Celiac Disease

$792,071
Lori R Holtz · Washington University · R01 · FY2024 · AI

A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver disease

$791,956
D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · UG3 · FY2021 · TR

A Social Epigenomic Approach to Health Disparities in Cardiovascular Risk Factors

$791,941
Jennifer Ann Smith · University Of Michigan At Ann Arbor · R01 · FY2018 · HL

(PQ4) Anal HPV infection and anal HSIL among HIV-infected MSM aged 50+ years

$791,933
Joel Palefsky · University Of California, San Francisco · R01 · FY2018 · CA

Bone And Tooth Matrix Biochemistry And Metabolism

$791,895
Larry W Fisher · National Institute Of Dental & Craniofacial Research · ZIA · FY2010 · DE

Systemic Bone Loss Following Fracture in Humans

$791,890
Galateia J Kazakia · University Of California, San Francisco · R01 · FY2023 · AG

Identifying Early Intervention Targets for Reducing Cardiovascular Risk in Posttraumatic Stress

$791,886
Jennifer A Sumner · University Of California Los Angeles · R01 · FY2019 · HL

EXposomic Profiling in Airway disease to uNravel Determinants of disease in Asthma (EXPAND-Asthma) Center

$791,874
Stephanie A Christenson · University Of California, San Francisco · U01 · FY2023 · HG

Impact of Celecoxib and Inflammation on Survival in Stage III Colon Cancer

$791,833
Charles S Fuchs · Dana-Farber Cancer Inst · R01 · FY2015 · CA

The Fetal and Childhood Environment, Oxidative Balance, Inflammation and Asthma

$791,822
Diane R Gold · Brigham And Women'S Hospital · R01 · FY2016 · AI

MR-compatible Devices for the Diagnosis and Treatment of Cardiomyopathies

$791,786
Dara L Kraitchman · Johns Hopkins University · R01 · FY2021 · HL

An Integrative Multi-Omics Approach to Elucidate Sex-Specific Differences in Alzheimers Disease

$791,705
Marina Sirota · University Of California, San Francisco · R01 · FY2022 · AG

Disease Modifying Biologics for Rheumatoid Arthritis

$791,681
Rekha Bansal · Novelmed Therapeutics, Inc. · R44 · FY2010 · AG

Understanding IgE Biology

$791,665
Duane R. Wesemann · Brigham And Women'S Hospital · R01 · FY2023 · AI

Understanding IgE Biology

$791,665
Duane R. Wesemann · Brigham And Women'S Hospital · R01 · FY2024 · AI

traThe influence of rectal Chlamydia trachomatis infections on immunity and incident urogenital infections in women without an indication forrectal screening

$791,657
Stephen J. Jordan · Indiana University Indianapolis · R01 · FY2025 · AI